Shilajit and Diabetes: What You Need to Know (2026 Guide)
Share
Shilajit and Diabetes: What the Evidence and Safety Considerations Actually Show
People with diabetes or prediabetes often ask whether Shilajit affects blood sugar, and whether it's safe to combine with their existing treatment. The honest answer starts with a clear statement: there is not enough high-quality human clinical evidence to recommend Shilajit for diabetes treatment, prevention, or glucose control.
Does Shilajit Lower Blood Sugar?
Some preclinical and limited research suggests Shilajit may influence glucose metabolism, but this does not establish a clinically proven glucose-lowering effect in people with diabetes. The honest answer here is not "yes" — it's that the evidence so far is early and insufficient to support that claim.
What About Insulin Sensitivity?
Claims about improved insulin sensitivity are not sufficiently established in human diabetes trials. Cellular or fulvic-acid mechanisms that are sometimes cited in this context are not the same as a demonstrated patient outcome, and should not be treated as one.
Can Shilajit Prevent or Treat Type 2 Diabetes?
No established evidence supports Shilajit as a prevention or treatment for type 2 diabetes, prediabetes, or metabolic syndrome. Claims involving cortisol-mediated prevention, pancreatic protection, or mineral replenishment as a form of treatment are not supported by reliable human evidence.
Shilajit and Diabetes Medications
Preclinical evidence suggests Shilajit may enhance glucose-lowering effects when combined with some antidiabetes medications. Because human interaction evidence is limited, people using insulin, metformin, sulfonylureas, or other glucose-lowering medication should discuss Shilajit with their physician or pharmacist before use. This is not a confirmed interaction in humans, but the possibility is serious enough to warrant a conversation with a healthcare professional rather than guesswork.
Risk of Hypoglycaemia
If a supplement has any glucose-lowering activity, combining it with diabetes medication could theoretically increase the risk of hypoglycaemia. This is not something to self-manage — it's a risk that should be assessed and monitored by a healthcare professional, particularly for anyone on insulin or other glucose-lowering therapy.
If Someone With Diabetes Still Wants to Use Shilajit
Anyone with diabetes considering Shilajit should start with professional medical advice and, if their clinician agrees, blood-glucose monitoring as directed. Beyond that, the priority shifts to product quality: documented batch-specific lab evidence, heavy-metal testing, and transparency about sourcing and purification.
Product Quality and Documented Evidence
Golden Shilajit Official publishes batch-specific laboratory documentation. The most recent documented batch is HI-SHL-0226, tested by three separate laboratories. Full detail is available on the HI-SHL-0226 batch evidence page and the Batch Verification hub.
| Laboratory | Reference | Key Results |
|---|---|---|
| Eurofins Scientific | Report 5374116-0, Sample 16388887, 21 May 2026 | Fulvic acid 46.80 g/100g (method IRXNK-Fulvic Acid, Gravimetric). Heavy metals (ICP_MS_S, per 500mg serving): Mercury <0.00250 mcg, Cadmium 0.00940 mcg, Lead 0.467 mcg, Arsenic 1.18 mcg. |
| Anresco Laboratories | Order 960349, Sample 1352051, 25 Aug 2026 | Method ICP-MS / MF24E022. Arsenic 4.941 µg/g (2.470 µg/day), Cadmium 0.024 µg/g (0.012 µg/day), Mercury ND, Lead 0.069 µg/g (0.035 µg/day). |
| TTI | Batch HI-SHL-0226 (report/order/sample IDs not published) | Fulvic acid 44.31%, method ISO 5073:2021. A different method than Eurofins, so the two figures are kept separate. |
"ND" means not detected under that method — not zero. The arsenic figures are total arsenic, not inorganic arsenic specifically. See our testing process and the full Lab Reports page.
Golden Shilajit's typical resin reference is 500 mg per day. This is general product guidance, not diabetes treatment guidance.
Frequently Asked Questions
Can people with diabetes take Shilajit?
Anyone with diabetes should speak with their doctor or pharmacist before using Shilajit, particularly because of a theoretical interaction with glucose-lowering medications.
Does Shilajit lower blood sugar?
Some limited and preclinical research suggests a possible effect on glucose metabolism, but this has not been established as a proven glucose-lowering effect in people with diabetes.
Does Shilajit improve insulin sensitivity?
This is not sufficiently established in human diabetes trials. Mechanistic research does not equal a proven patient outcome.
Can Shilajit interact with metformin or insulin?
A theoretical interaction is possible based on preclinical evidence. Anyone using metformin, insulin, or other glucose-lowering medication should discuss Shilajit with their physician or pharmacist first.
Can Shilajit cause hypoglycaemia?
On its own, this isn't well documented, but combining Shilajit with diabetes medication could theoretically increase that risk. This should be monitored by a healthcare professional.
How can I verify the quality of a Shilajit product?
Check for a specific batch ID, a named independent laboratory, the analytical method used, and the actual reported result. See the Lab Reports page and the batch evidence page.